Parameters | Tertile 1 n = 131 | Tertile 2 n = 77 | Tertile 3 n = 67 | P value |
---|---|---|---|---|
Age, years (SD) | 55.1 ± 7.5 | 57.1 ± 10.6 | 60.6 ± 10.4 | 0.001 |
Male, sex, n (%) | 85 (64.8%) | 55 (71.4%) | 51 (76.1%) | 0.395 |
Paroxysmal AF, n (%) | 91 (69.5%) | 56 (72.7%) | 48 (71.6%) | 0.654 |
AF duration, months (SD) | 62.3 ± 60.4 | 67.9 ± 50.9 | 69.8 ± 62.8 | 0.168 |
BMI, kg/m2 | 25.2 ± 2.0 | 25.7 ± 3.2 | 26.3 ± 3.1 | 0.027 |
CAD history, n (%) | 15 (11.4%) | 12 (15.6%) | 9 (13.4%) | 0.096 |
Hypertension, n (%) | 70 (53.4%) | 41 (53.2%) | 28 (41.8%) | 0.068 |
SAS history, n (%) | 16 (12.2%) | 11 (14.3%) | 10 (14.9%) | 0.218 |
Previous stroke/TIA, n (%) | 6 (4.6%) | 4 (5.2%) | 3 (4.5%) | 0.452 |
Echocardiography | ||||
LAD, mm | 38.1 ± 4.7 | 39.0 ± 4.5 | 41.9 ± 4.8 | 0.035 |
LVEF (%) | 64.0 ± 5.3 | 63.8 ± 5.1 | 64.5 ± 5.7 | 0.674 |
Biochemistry | ||||
NT-proBNP, pg/mL | 245.7 ± 282.7 | 275.3 ± 325.0 | 368.2 ± 379.0 | 0.001 |
hs-CRP, mg/L | 2.4 ± 1.6 | 3.5 ± 3.8 | 4.8 ± 4.9 | 0.001 |
Uric acid,umol/L | 332.5 ± 80.5 | 338.3 ± 81.2 | 346.5 ± 79.5 | 0.352 |
HCy, μmol/L | 16.2 ± 1.5 | 18.2 ± 2.1 | 18.6 ± 2.2 | 0.115 |
Risk scoring system | ||||
CHA2DS2-VASc score | 1 (1–2) | 1 (1–2) | 2 (1–3) | 0.025 |
APPLE score | 1 (0–1) | 1 (1–2) | 2 (1–3) | 0.010 |
DR-FLASH score | 1 (0–2) | 2 (1–2) | 3 (2–4) | 0.010 |